Delivery Order SPE2DB20D9329-SPE2DB23FZM07
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $7,811.55 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the procurement of 4,567,759,894 units of the Mirena 52 mg contraceptive system. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a wide range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,840.00 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4566087887 MIRENA 52 MG SYSTEMS. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 with DMS Pharmaceutical Group that runs through December 31, 2025. The IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,184.00 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of MIRENA 52 MG SYSTEMS. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through the end of 2025. Through this IDV, DLA can issue firm-fixed-price delivery orders for a broad range of pharmaceutical items to...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $29,048.00, is for the delivery of Mirena 52 mg systems to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to $499,999,999, that allows DLA to issue orders...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide the MIRENA 52 MG SYSTEMS pharmaceutical product. The $11,840.00 firm fixed-price contract has a period of performance through May 31, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which allows the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth up to $1,184.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,564,029,380 units of Mirena 52 mg contraceptive intrauterine systems. The delivery order has an ultimate completion date of April 8, 2024 and was awarded on March 18, 2024. This contract is part of DMS Pharmaceutical Group's existing indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,776.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has no set-aside designation, is for the delivery of Mirena 52 mg systems to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger single-award indefinite delivery contract (IDC) valued...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Mirena 52 mg systems. The contract, valued at $1,184.00, has an ultimate completion date of October 10, 2024. DMS Pharmaceutical Group holds a larger single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which allows the agency to issue...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $8,880.00, is for the delivery of Mirena 52 mg contraceptive systems to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by the DLA to DMS Pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,564,414,792 units of the Mirena 52 mg intrauterine contraceptive system. The contract has a ceiling value of $11,840.00 and an ultimate completion date of May 15, 2024. This delivery order was issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (SPE2DB) with the DLA's Medical Supply Chain...
- SPE2DB20D9329Indefinite Delivery Contract
- SPE2DB20D9329-SPE2DB23FZM07Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the delivery of 4,562,293,327 units of Mirena 52 mg systems. The award, valued at $29,048.00, has an ultimate completion date of October 11, 2023. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which runs through December 31, 2025. The IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. There is no set-aside designation for this particular award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.0k | 9/19/23 |